Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$924K Buy
7,689
+30
+0.4% +$3.46K 0.27% 64
2025
Q4
$914K Buy
7,659
+555
+8% +$52.1K 0.27% 62
2025
Q3
$611K Buy
7,104
+5
+0.1% +$412 0.21% 73
2025
Q2
$592K Buy
7,099
+821
+13% +$65.3K 0.21% 73
2025
Q1
$496K Buy
+6,278
New +$586K 0.22% 74
2024
Q3
$747K Buy
6,873
+221
+3% +$26.3K 0.29% 59
2024
Q2
$838K Buy
6,652
+28
+0.4% +$3.61K 0.36% 48
2024
Q1
$852K Buy
+6,624
New +$816K 0.38% 46
2023
Q3
$833K Sell
7,975
-16,785
-68% -$1.81M 0.44% 42
2023
Q2
$2.63M Buy
24,760
+697
+3% +$79.1K 1.36% 17
2023
Q1
$2.65M Buy
+24,063
New +$2.6M 1.41% 17

Other funds holding MRK

Sweeney & Michel's MRK Position: Q1 2026 in Review

Sweeney & Michel increased its Merck (MRK) stake by 0.39% in Q1 2026, buying an estimated $3.46K and bringing the position to 7,689 shares worth $924K. The position accounts for 0.27% of the portfolio, ranked #64.

Sweeney & Michel first reported a position in MRK in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.65M in Q1 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sweeney & Michel held 7,689 shares of Merck worth $924K as of Q1 2026.
  • Sweeney & Michel bought 30 Merck shares in Q1 2026, an estimated $3.46K.
  • Merck made up 0.27% of Sweeney & Michel's portfolio in Q1 2026, its #64 holding.
  • Sweeney & Michel first reported a position in Merck in Q1 2023 and has held it in 11 quarters since.
  • Sweeney & Michel's Merck position peaked at $2.65M in Q1 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sweeney & Michel's 13F filing for Q1 2026, filed 16 Apr 2026.